mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.1 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.062 |
0.1 |